Category: Latest News

Sepo III is a study that aimed to identify and showcase ‘promising practices’ (e.g. policies, programs, services, community initiatives, or other innovations) providing support for young people (0-24 years of age) living with HIV. MEDIA BRIEF LINK

The PopART trial, also known as HPTN 071, delivered community-wide HIV prevention interventions in combination with universal test and treat to 21 communities in Zambia and South Africa. PRESS RELEASE LINK

View all the  Zambart Staff posters @IAS2019, Mexico City, Mexico. Click HERE to view full poster     Click HERE to view full poster     Click HERE to view full poster

Zambart has been awarded a contract to conduct the 2019 National TB Drug Resistance Survey (DRS) by the Ministry of Health (MoH). The project is expected to take 15 months. Zambart previously conducted the 2001 and 2008 DRS on behalf…

Zambart has had a long standing affiliation with the Ministry of Health since starting out as a small research unit under collaboration between the University of Zambia and the London School of Hygiene and Tropical Medicine (LSHTM). In Lusaka district,…

  Tuberculosis (TB) still remains one of the world’s top 10 causes of death. According to the World Health Organization, 10 million people fell ill with TB, and 1.6 million died from the disease (including 0.3 million among people living…

What is HPTN 071 (PopART)?   HPTN 071 – Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART) is a research study that examined the impact of a package of HIV prevention interventions on community-level HIV incidence.  The prevention…